nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—SLC1A1—renal system—muscle cancer	0.015	0.109	CbGeAlD
Pregabalin—SLC1A1—tendon—muscle cancer	0.0117	0.0854	CbGeAlD
Pregabalin—SLC1A1—vagina—muscle cancer	0.0109	0.0792	CbGeAlD
Pregabalin—CACNA1A—head—muscle cancer	0.0103	0.075	CbGeAlD
Pregabalin—SLC1A1—head—muscle cancer	0.0101	0.0732	CbGeAlD
Pregabalin—CACNA1A—testis—muscle cancer	0.00996	0.0724	CbGeAlD
Pregabalin—SLC1A1—testis—muscle cancer	0.00972	0.0707	CbGeAlD
Pregabalin—CACNA2D2—cardiac atrium—muscle cancer	0.00972	0.0707	CbGeAlD
Pregabalin—CACNA2D2—vagina—muscle cancer	0.00786	0.0571	CbGeAlD
Pregabalin—CACNA2D2—head—muscle cancer	0.00726	0.0528	CbGeAlD
Pregabalin—CACNA2D2—testis—muscle cancer	0.00701	0.051	CbGeAlD
Pregabalin—CACNA2D1—tendon—muscle cancer	0.00609	0.0443	CbGeAlD
Pregabalin—CACNA2D1—bone marrow—muscle cancer	0.0059	0.0429	CbGeAlD
Pregabalin—CACNA2D1—vagina—muscle cancer	0.00565	0.0411	CbGeAlD
Pregabalin—CACNA2D1—head—muscle cancer	0.00522	0.038	CbGeAlD
Pregabalin—CACNA2D1—testis—muscle cancer	0.00504	0.0367	CbGeAlD
Pregabalin—Tachycardia—Etoposide—muscle cancer	0.000536	0.000622	CcSEcCtD
Pregabalin—Body temperature increased—Vincristine—muscle cancer	0.000536	0.000622	CcSEcCtD
Pregabalin—Abdominal pain—Vincristine—muscle cancer	0.000536	0.000622	CcSEcCtD
Pregabalin—Liver function test abnormal—Doxorubicin—muscle cancer	0.000535	0.000621	CcSEcCtD
Pregabalin—Skin disorder—Etoposide—muscle cancer	0.000534	0.000619	CcSEcCtD
Pregabalin—Erectile dysfunction—Methotrexate—muscle cancer	0.000533	0.000618	CcSEcCtD
Pregabalin—Dry skin—Doxorubicin—muscle cancer	0.000531	0.000616	CcSEcCtD
Pregabalin—Hyperhidrosis—Etoposide—muscle cancer	0.000531	0.000616	CcSEcCtD
Pregabalin—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00053	0.000614	CcSEcCtD
Pregabalin—Photosensitivity reaction—Methotrexate—muscle cancer	0.000528	0.000612	CcSEcCtD
Pregabalin—Hypokalaemia—Doxorubicin—muscle cancer	0.000528	0.000612	CcSEcCtD
Pregabalin—Breast disorder—Doxorubicin—muscle cancer	0.000524	0.000608	CcSEcCtD
Pregabalin—Anorexia—Etoposide—muscle cancer	0.000524	0.000607	CcSEcCtD
Pregabalin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	0.000522	0.000605	CcSEcCtD
Pregabalin—Diarrhoea—Dactinomycin—muscle cancer	0.000519	0.000602	CcSEcCtD
Pregabalin—Pneumonia—Methotrexate—muscle cancer	0.000519	0.000602	CcSEcCtD
Pregabalin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000518	0.000601	CcSEcCtD
Pregabalin—Infestation NOS—Methotrexate—muscle cancer	0.000516	0.000598	CcSEcCtD
Pregabalin—Infestation—Methotrexate—muscle cancer	0.000516	0.000598	CcSEcCtD
Pregabalin—Depression—Methotrexate—muscle cancer	0.000515	0.000597	CcSEcCtD
Pregabalin—Hypotension—Etoposide—muscle cancer	0.000513	0.000595	CcSEcCtD
Pregabalin—Gastritis—Doxorubicin—muscle cancer	0.000513	0.000595	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000512	0.000593	CcSEcCtD
Pregabalin—Muscular weakness—Doxorubicin—muscle cancer	0.000511	0.000593	CcSEcCtD
Pregabalin—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000511	0.000593	CcSEcCtD
Pregabalin—Renal failure—Methotrexate—muscle cancer	0.000507	0.000588	CcSEcCtD
Pregabalin—Abdominal distension—Doxorubicin—muscle cancer	0.000505	0.000585	CcSEcCtD
Pregabalin—Stomatitis—Methotrexate—muscle cancer	0.000503	0.000583	CcSEcCtD
Pregabalin—Conjunctivitis—Methotrexate—muscle cancer	0.000502	0.000582	CcSEcCtD
Pregabalin—Asthma—Doxorubicin—muscle cancer	0.000501	0.000581	CcSEcCtD
Pregabalin—Dysphagia—Doxorubicin—muscle cancer	0.000501	0.000581	CcSEcCtD
Pregabalin—Influenza—Doxorubicin—muscle cancer	0.000501	0.000581	CcSEcCtD
Pregabalin—Hypersensitivity—Vincristine—muscle cancer	0.0005	0.000579	CcSEcCtD
Pregabalin—Eosinophilia—Doxorubicin—muscle cancer	0.000496	0.000575	CcSEcCtD
Pregabalin—Sweating—Methotrexate—muscle cancer	0.000495	0.000574	CcSEcCtD
Pregabalin—Paraesthesia—Etoposide—muscle cancer	0.000493	0.000572	CcSEcCtD
Pregabalin—Haematuria—Methotrexate—muscle cancer	0.000492	0.00057	CcSEcCtD
Pregabalin—Pancreatitis—Doxorubicin—muscle cancer	0.000491	0.00057	CcSEcCtD
Pregabalin—Dyspnoea—Etoposide—muscle cancer	0.00049	0.000568	CcSEcCtD
Pregabalin—Somnolence—Etoposide—muscle cancer	0.000488	0.000566	CcSEcCtD
Pregabalin—Angina pectoris—Doxorubicin—muscle cancer	0.000488	0.000566	CcSEcCtD
Pregabalin—Epistaxis—Methotrexate—muscle cancer	0.000487	0.000564	CcSEcCtD
Pregabalin—Asthenia—Vincristine—muscle cancer	0.000487	0.000564	CcSEcCtD
Pregabalin—Vomiting—Dactinomycin—muscle cancer	0.000483	0.00056	CcSEcCtD
Pregabalin—Bronchitis—Doxorubicin—muscle cancer	0.000482	0.000559	CcSEcCtD
Pregabalin—Rash—Dactinomycin—muscle cancer	0.000479	0.000555	CcSEcCtD
Pregabalin—Decreased appetite—Etoposide—muscle cancer	0.000478	0.000554	CcSEcCtD
Pregabalin—Pancytopenia—Doxorubicin—muscle cancer	0.000476	0.000552	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000474	0.00055	CcSEcCtD
Pregabalin—Fatigue—Etoposide—muscle cancer	0.000474	0.000549	CcSEcCtD
Pregabalin—Constipation—Etoposide—muscle cancer	0.00047	0.000545	CcSEcCtD
Pregabalin—Pain—Etoposide—muscle cancer	0.00047	0.000545	CcSEcCtD
Pregabalin—Neutropenia—Doxorubicin—muscle cancer	0.000469	0.000543	CcSEcCtD
Pregabalin—Dysuria—Doxorubicin—muscle cancer	0.000469	0.000543	CcSEcCtD
Pregabalin—Haemoglobin—Methotrexate—muscle cancer	0.000466	0.00054	CcSEcCtD
Pregabalin—Diarrhoea—Vincristine—muscle cancer	0.000464	0.000538	CcSEcCtD
Pregabalin—Haemorrhage—Methotrexate—muscle cancer	0.000463	0.000537	CcSEcCtD
Pregabalin—Hepatitis—Methotrexate—muscle cancer	0.000463	0.000537	CcSEcCtD
Pregabalin—Pollakiuria—Doxorubicin—muscle cancer	0.000463	0.000537	CcSEcCtD
Pregabalin—Pharyngitis—Methotrexate—muscle cancer	0.00046	0.000533	CcSEcCtD
Pregabalin—Urinary tract disorder—Methotrexate—muscle cancer	0.000457	0.00053	CcSEcCtD
Pregabalin—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000457	0.00053	CcSEcCtD
Pregabalin—Weight increased—Doxorubicin—muscle cancer	0.000456	0.000529	CcSEcCtD
Pregabalin—Urethral disorder—Methotrexate—muscle cancer	0.000454	0.000527	CcSEcCtD
Pregabalin—Weight decreased—Doxorubicin—muscle cancer	0.000453	0.000526	CcSEcCtD
Pregabalin—Feeling abnormal—Etoposide—muscle cancer	0.000453	0.000525	CcSEcCtD
Pregabalin—Hyperglycaemia—Doxorubicin—muscle cancer	0.000452	0.000524	CcSEcCtD
Pregabalin—Nausea—Dactinomycin—muscle cancer	0.000451	0.000523	CcSEcCtD
Pregabalin—Pneumonia—Doxorubicin—muscle cancer	0.000449	0.000521	CcSEcCtD
Pregabalin—Gastrointestinal pain—Etoposide—muscle cancer	0.000449	0.000521	CcSEcCtD
Pregabalin—Dizziness—Vincristine—muscle cancer	0.000449	0.00052	CcSEcCtD
Pregabalin—Infestation NOS—Doxorubicin—muscle cancer	0.000447	0.000518	CcSEcCtD
Pregabalin—Infestation—Doxorubicin—muscle cancer	0.000447	0.000518	CcSEcCtD
Pregabalin—Visual impairment—Methotrexate—muscle cancer	0.000446	0.000518	CcSEcCtD
Pregabalin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000443	0.000514	CcSEcCtD
Pregabalin—Renal failure—Doxorubicin—muscle cancer	0.000439	0.000509	CcSEcCtD
Pregabalin—Erythema multiforme—Methotrexate—muscle cancer	0.000438	0.000508	CcSEcCtD
Pregabalin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000438	0.000508	CcSEcCtD
Pregabalin—Urticaria—Etoposide—muscle cancer	0.000436	0.000506	CcSEcCtD
Pregabalin—Stomatitis—Doxorubicin—muscle cancer	0.000436	0.000505	CcSEcCtD
Pregabalin—Jaundice—Doxorubicin—muscle cancer	0.000436	0.000505	CcSEcCtD
Pregabalin—Abdominal pain—Etoposide—muscle cancer	0.000434	0.000504	CcSEcCtD
Pregabalin—Body temperature increased—Etoposide—muscle cancer	0.000434	0.000504	CcSEcCtD
Pregabalin—Urinary tract infection—Doxorubicin—muscle cancer	0.000434	0.000504	CcSEcCtD
Pregabalin—Conjunctivitis—Doxorubicin—muscle cancer	0.000434	0.000504	CcSEcCtD
Pregabalin—Eye disorder—Methotrexate—muscle cancer	0.000433	0.000502	CcSEcCtD
Pregabalin—Tinnitus—Methotrexate—muscle cancer	0.000432	0.000501	CcSEcCtD
Pregabalin—Vomiting—Vincristine—muscle cancer	0.000431	0.0005	CcSEcCtD
Pregabalin—Cardiac disorder—Methotrexate—muscle cancer	0.00043	0.000498	CcSEcCtD
Pregabalin—Sweating—Doxorubicin—muscle cancer	0.000428	0.000497	CcSEcCtD
Pregabalin—Rash—Vincristine—muscle cancer	0.000428	0.000496	CcSEcCtD
Pregabalin—Dermatitis—Vincristine—muscle cancer	0.000427	0.000495	CcSEcCtD
Pregabalin—Haematuria—Doxorubicin—muscle cancer	0.000426	0.000494	CcSEcCtD
Pregabalin—Headache—Vincristine—muscle cancer	0.000425	0.000493	CcSEcCtD
Pregabalin—Epistaxis—Doxorubicin—muscle cancer	0.000421	0.000489	CcSEcCtD
Pregabalin—Angiopathy—Methotrexate—muscle cancer	0.00042	0.000487	CcSEcCtD
Pregabalin—Sinusitis—Doxorubicin—muscle cancer	0.000419	0.000486	CcSEcCtD
Pregabalin—Immune system disorder—Methotrexate—muscle cancer	0.000418	0.000485	CcSEcCtD
Pregabalin—Mediastinal disorder—Methotrexate—muscle cancer	0.000417	0.000484	CcSEcCtD
Pregabalin—Chills—Methotrexate—muscle cancer	0.000416	0.000482	CcSEcCtD
Pregabalin—Alopecia—Methotrexate—muscle cancer	0.000409	0.000475	CcSEcCtD
Pregabalin—Bradycardia—Doxorubicin—muscle cancer	0.000408	0.000473	CcSEcCtD
Pregabalin—Mental disorder—Methotrexate—muscle cancer	0.000406	0.000471	CcSEcCtD
Pregabalin—Hypersensitivity—Etoposide—muscle cancer	0.000405	0.000469	CcSEcCtD
Pregabalin—Malnutrition—Methotrexate—muscle cancer	0.000403	0.000468	CcSEcCtD
Pregabalin—Haemoglobin—Doxorubicin—muscle cancer	0.000403	0.000467	CcSEcCtD
Pregabalin—Nausea—Vincristine—muscle cancer	0.000403	0.000467	CcSEcCtD
Pregabalin—Rhinitis—Doxorubicin—muscle cancer	0.000402	0.000466	CcSEcCtD
Pregabalin—Haemorrhage—Doxorubicin—muscle cancer	0.000401	0.000465	CcSEcCtD
Pregabalin—Hepatitis—Doxorubicin—muscle cancer	0.000401	0.000465	CcSEcCtD
Pregabalin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000399	0.000463	CcSEcCtD
Pregabalin—Pharyngitis—Doxorubicin—muscle cancer	0.000398	0.000462	CcSEcCtD
Pregabalin—Urinary tract disorder—Doxorubicin—muscle cancer	0.000396	0.000459	CcSEcCtD
Pregabalin—Oedema peripheral—Doxorubicin—muscle cancer	0.000395	0.000458	CcSEcCtD
Pregabalin—Dysgeusia—Methotrexate—muscle cancer	0.000395	0.000458	CcSEcCtD
Pregabalin—Asthenia—Etoposide—muscle cancer	0.000394	0.000457	CcSEcCtD
Pregabalin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000394	0.000457	CcSEcCtD
Pregabalin—Urethral disorder—Doxorubicin—muscle cancer	0.000393	0.000456	CcSEcCtD
Pregabalin—Back pain—Methotrexate—muscle cancer	0.00039	0.000452	CcSEcCtD
Pregabalin—Pruritus—Etoposide—muscle cancer	0.000389	0.000451	CcSEcCtD
Pregabalin—Visual impairment—Doxorubicin—muscle cancer	0.000387	0.000448	CcSEcCtD
Pregabalin—Vision blurred—Methotrexate—muscle cancer	0.00038	0.000441	CcSEcCtD
Pregabalin—Erythema multiforme—Doxorubicin—muscle cancer	0.000379	0.00044	CcSEcCtD
Pregabalin—Diarrhoea—Etoposide—muscle cancer	0.000376	0.000436	CcSEcCtD
Pregabalin—Eye disorder—Doxorubicin—muscle cancer	0.000375	0.000435	CcSEcCtD
Pregabalin—Ill-defined disorder—Methotrexate—muscle cancer	0.000374	0.000434	CcSEcCtD
Pregabalin—Tinnitus—Doxorubicin—muscle cancer	0.000374	0.000434	CcSEcCtD
Pregabalin—Anaemia—Methotrexate—muscle cancer	0.000373	0.000432	CcSEcCtD
Pregabalin—Cardiac disorder—Doxorubicin—muscle cancer	0.000372	0.000432	CcSEcCtD
Pregabalin—Flushing—Doxorubicin—muscle cancer	0.000372	0.000432	CcSEcCtD
Pregabalin—Angiopathy—Doxorubicin—muscle cancer	0.000364	0.000422	CcSEcCtD
Pregabalin—Malaise—Methotrexate—muscle cancer	0.000364	0.000422	CcSEcCtD
Pregabalin—Dizziness—Etoposide—muscle cancer	0.000363	0.000421	CcSEcCtD
Pregabalin—Immune system disorder—Doxorubicin—muscle cancer	0.000362	0.00042	CcSEcCtD
Pregabalin—Vertigo—Methotrexate—muscle cancer	0.000362	0.00042	CcSEcCtD
Pregabalin—Mediastinal disorder—Doxorubicin—muscle cancer	0.000362	0.000419	CcSEcCtD
Pregabalin—Leukopenia—Methotrexate—muscle cancer	0.000361	0.000419	CcSEcCtD
Pregabalin—Chills—Doxorubicin—muscle cancer	0.00036	0.000417	CcSEcCtD
Pregabalin—Arrhythmia—Doxorubicin—muscle cancer	0.000358	0.000415	CcSEcCtD
Pregabalin—Alopecia—Doxorubicin—muscle cancer	0.000354	0.000411	CcSEcCtD
Pregabalin—Cough—Methotrexate—muscle cancer	0.000352	0.000408	CcSEcCtD
Pregabalin—Mental disorder—Doxorubicin—muscle cancer	0.000351	0.000407	CcSEcCtD
Pregabalin—Convulsion—Methotrexate—muscle cancer	0.000349	0.000405	CcSEcCtD
Pregabalin—Vomiting—Etoposide—muscle cancer	0.000349	0.000405	CcSEcCtD
Pregabalin—Malnutrition—Doxorubicin—muscle cancer	0.000349	0.000405	CcSEcCtD
Pregabalin—Rash—Etoposide—muscle cancer	0.000346	0.000402	CcSEcCtD
Pregabalin—Dermatitis—Etoposide—muscle cancer	0.000346	0.000401	CcSEcCtD
Pregabalin—Headache—Etoposide—muscle cancer	0.000344	0.000399	CcSEcCtD
Pregabalin—Flatulence—Doxorubicin—muscle cancer	0.000344	0.000399	CcSEcCtD
Pregabalin—Myalgia—Methotrexate—muscle cancer	0.000343	0.000398	CcSEcCtD
Pregabalin—Chest pain—Methotrexate—muscle cancer	0.000343	0.000398	CcSEcCtD
Pregabalin—Arthralgia—Methotrexate—muscle cancer	0.000343	0.000398	CcSEcCtD
Pregabalin—Tension—Doxorubicin—muscle cancer	0.000343	0.000397	CcSEcCtD
Pregabalin—Dysgeusia—Doxorubicin—muscle cancer	0.000342	0.000396	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000341	0.000395	CcSEcCtD
Pregabalin—Discomfort—Methotrexate—muscle cancer	0.000339	0.000393	CcSEcCtD
Pregabalin—Nervousness—Doxorubicin—muscle cancer	0.000339	0.000393	CcSEcCtD
Pregabalin—Back pain—Doxorubicin—muscle cancer	0.000338	0.000392	CcSEcCtD
Pregabalin—Muscle spasms—Doxorubicin—muscle cancer	0.000336	0.000389	CcSEcCtD
Pregabalin—Confusional state—Methotrexate—muscle cancer	0.000332	0.000385	CcSEcCtD
Pregabalin—Anaphylactic shock—Methotrexate—muscle cancer	0.000329	0.000382	CcSEcCtD
Pregabalin—Vision blurred—Doxorubicin—muscle cancer	0.000329	0.000382	CcSEcCtD
Pregabalin—Infection—Methotrexate—muscle cancer	0.000327	0.000379	CcSEcCtD
Pregabalin—Nausea—Etoposide—muscle cancer	0.000326	0.000378	CcSEcCtD
Pregabalin—Ill-defined disorder—Doxorubicin—muscle cancer	0.000324	0.000376	CcSEcCtD
Pregabalin—Nervous system disorder—Methotrexate—muscle cancer	0.000323	0.000374	CcSEcCtD
Pregabalin—Anaemia—Doxorubicin—muscle cancer	0.000323	0.000374	CcSEcCtD
Pregabalin—Thrombocytopenia—Methotrexate—muscle cancer	0.000322	0.000374	CcSEcCtD
Pregabalin—Agitation—Doxorubicin—muscle cancer	0.000321	0.000372	CcSEcCtD
Pregabalin—Skin disorder—Methotrexate—muscle cancer	0.00032	0.000371	CcSEcCtD
Pregabalin—Hyperhidrosis—Methotrexate—muscle cancer	0.000318	0.000369	CcSEcCtD
Pregabalin—Malaise—Doxorubicin—muscle cancer	0.000315	0.000365	CcSEcCtD
Pregabalin—Vertigo—Doxorubicin—muscle cancer	0.000314	0.000364	CcSEcCtD
Pregabalin—Anorexia—Methotrexate—muscle cancer	0.000314	0.000364	CcSEcCtD
Pregabalin—Syncope—Doxorubicin—muscle cancer	0.000313	0.000363	CcSEcCtD
Pregabalin—Leukopenia—Doxorubicin—muscle cancer	0.000313	0.000362	CcSEcCtD
Pregabalin—Palpitations—Doxorubicin—muscle cancer	0.000309	0.000358	CcSEcCtD
Pregabalin—Hypotension—Methotrexate—muscle cancer	0.000308	0.000357	CcSEcCtD
Pregabalin—Loss of consciousness—Doxorubicin—muscle cancer	0.000307	0.000356	CcSEcCtD
Pregabalin—Cough—Doxorubicin—muscle cancer	0.000305	0.000353	CcSEcCtD
Pregabalin—Convulsion—Doxorubicin—muscle cancer	0.000303	0.000351	CcSEcCtD
Pregabalin—Hypertension—Doxorubicin—muscle cancer	0.000301	0.00035	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.0003	0.000348	CcSEcCtD
Pregabalin—Insomnia—Methotrexate—muscle cancer	0.000298	0.000345	CcSEcCtD
Pregabalin—Myalgia—Doxorubicin—muscle cancer	0.000297	0.000345	CcSEcCtD
Pregabalin—Arthralgia—Doxorubicin—muscle cancer	0.000297	0.000345	CcSEcCtD
Pregabalin—Chest pain—Doxorubicin—muscle cancer	0.000297	0.000345	CcSEcCtD
Pregabalin—Anxiety—Doxorubicin—muscle cancer	0.000296	0.000343	CcSEcCtD
Pregabalin—Paraesthesia—Methotrexate—muscle cancer	0.000296	0.000343	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000295	0.000342	CcSEcCtD
Pregabalin—Discomfort—Doxorubicin—muscle cancer	0.000294	0.000341	CcSEcCtD
Pregabalin—Dyspnoea—Methotrexate—muscle cancer	0.000293	0.00034	CcSEcCtD
Pregabalin—Somnolence—Methotrexate—muscle cancer	0.000293	0.000339	CcSEcCtD
Pregabalin—Dry mouth—Doxorubicin—muscle cancer	0.000291	0.000337	CcSEcCtD
Pregabalin—Confusional state—Doxorubicin—muscle cancer	0.000287	0.000333	CcSEcCtD
Pregabalin—Decreased appetite—Methotrexate—muscle cancer	0.000286	0.000332	CcSEcCtD
Pregabalin—Oedema—Doxorubicin—muscle cancer	0.000285	0.00033	CcSEcCtD
Pregabalin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000285	0.00033	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000284	0.000329	CcSEcCtD
Pregabalin—Fatigue—Methotrexate—muscle cancer	0.000284	0.000329	CcSEcCtD
Pregabalin—Infection—Doxorubicin—muscle cancer	0.000283	0.000328	CcSEcCtD
Pregabalin—Pain—Methotrexate—muscle cancer	0.000281	0.000326	CcSEcCtD
Pregabalin—Shock—Doxorubicin—muscle cancer	0.00028	0.000325	CcSEcCtD
Pregabalin—Nervous system disorder—Doxorubicin—muscle cancer	0.000279	0.000324	CcSEcCtD
Pregabalin—Thrombocytopenia—Doxorubicin—muscle cancer	0.000279	0.000324	CcSEcCtD
Pregabalin—Tachycardia—Doxorubicin—muscle cancer	0.000278	0.000322	CcSEcCtD
Pregabalin—Skin disorder—Doxorubicin—muscle cancer	0.000277	0.000321	CcSEcCtD
Pregabalin—Hyperhidrosis—Doxorubicin—muscle cancer	0.000275	0.000319	CcSEcCtD
Pregabalin—Anorexia—Doxorubicin—muscle cancer	0.000272	0.000315	CcSEcCtD
Pregabalin—Feeling abnormal—Methotrexate—muscle cancer	0.000271	0.000314	CcSEcCtD
Pregabalin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000269	0.000312	CcSEcCtD
Pregabalin—Hypotension—Doxorubicin—muscle cancer	0.000266	0.000309	CcSEcCtD
Pregabalin—Urticaria—Methotrexate—muscle cancer	0.000261	0.000303	CcSEcCtD
Pregabalin—Abdominal pain—Methotrexate—muscle cancer	0.00026	0.000302	CcSEcCtD
Pregabalin—Body temperature increased—Methotrexate—muscle cancer	0.00026	0.000302	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00026	0.000301	CcSEcCtD
Pregabalin—Insomnia—Doxorubicin—muscle cancer	0.000258	0.000299	CcSEcCtD
Pregabalin—Paraesthesia—Doxorubicin—muscle cancer	0.000256	0.000297	CcSEcCtD
Pregabalin—Dyspnoea—Doxorubicin—muscle cancer	0.000254	0.000295	CcSEcCtD
Pregabalin—Somnolence—Doxorubicin—muscle cancer	0.000253	0.000294	CcSEcCtD
Pregabalin—Decreased appetite—Doxorubicin—muscle cancer	0.000248	0.000287	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000246	0.000285	CcSEcCtD
Pregabalin—Fatigue—Doxorubicin—muscle cancer	0.000246	0.000285	CcSEcCtD
Pregabalin—Pain—Doxorubicin—muscle cancer	0.000244	0.000283	CcSEcCtD
Pregabalin—Constipation—Doxorubicin—muscle cancer	0.000244	0.000283	CcSEcCtD
Pregabalin—Hypersensitivity—Methotrexate—muscle cancer	0.000242	0.000281	CcSEcCtD
Pregabalin—Asthenia—Methotrexate—muscle cancer	0.000236	0.000274	CcSEcCtD
Pregabalin—Feeling abnormal—Doxorubicin—muscle cancer	0.000235	0.000272	CcSEcCtD
Pregabalin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000233	0.00027	CcSEcCtD
Pregabalin—Pruritus—Methotrexate—muscle cancer	0.000233	0.00027	CcSEcCtD
Pregabalin—Urticaria—Doxorubicin—muscle cancer	0.000226	0.000262	CcSEcCtD
Pregabalin—Abdominal pain—Doxorubicin—muscle cancer	0.000225	0.000261	CcSEcCtD
Pregabalin—Body temperature increased—Doxorubicin—muscle cancer	0.000225	0.000261	CcSEcCtD
Pregabalin—Diarrhoea—Methotrexate—muscle cancer	0.000225	0.000261	CcSEcCtD
Pregabalin—Dizziness—Methotrexate—muscle cancer	0.000218	0.000252	CcSEcCtD
Pregabalin—Hypersensitivity—Doxorubicin—muscle cancer	0.00021	0.000243	CcSEcCtD
Pregabalin—Vomiting—Methotrexate—muscle cancer	0.000209	0.000243	CcSEcCtD
Pregabalin—Rash—Methotrexate—muscle cancer	0.000208	0.000241	CcSEcCtD
Pregabalin—Dermatitis—Methotrexate—muscle cancer	0.000207	0.00024	CcSEcCtD
Pregabalin—Headache—Methotrexate—muscle cancer	0.000206	0.000239	CcSEcCtD
Pregabalin—Asthenia—Doxorubicin—muscle cancer	0.000204	0.000237	CcSEcCtD
Pregabalin—Pruritus—Doxorubicin—muscle cancer	0.000202	0.000234	CcSEcCtD
Pregabalin—Nausea—Methotrexate—muscle cancer	0.000195	0.000227	CcSEcCtD
Pregabalin—Diarrhoea—Doxorubicin—muscle cancer	0.000195	0.000226	CcSEcCtD
Pregabalin—Dizziness—Doxorubicin—muscle cancer	0.000188	0.000218	CcSEcCtD
Pregabalin—Vomiting—Doxorubicin—muscle cancer	0.000181	0.00021	CcSEcCtD
Pregabalin—Rash—Doxorubicin—muscle cancer	0.00018	0.000208	CcSEcCtD
Pregabalin—Dermatitis—Doxorubicin—muscle cancer	0.00018	0.000208	CcSEcCtD
Pregabalin—Headache—Doxorubicin—muscle cancer	0.000179	0.000207	CcSEcCtD
Pregabalin—Nausea—Doxorubicin—muscle cancer	0.000169	0.000196	CcSEcCtD
